Proteins and Peptides

01 Jun 2007 Top line results of phase III study in acute ischemic stroke (DIAS-2) do not demonstrate difference between desmoteplase and placebo
26 May 2007 Mircera receives positive opinion in Europe for the treatment of anaemia due to chronic kidney disease
26 May 2007 Tercica Reports Increlex Receives CHMP Positive Opinion for the Treatment of Severe Primary IGF-1 Deficiency
25 May 2007 Emisphere Announces Initiation of Phase III Clinical Program of Oral Calcitonin for the Treatment of Osteoarthritis
24 May 2007 Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at Annual Meeting of American Urological Association
24 May 2007 Northfield Laboratories Reports Results of Pivotal Phase III Trauma Study
23 May 2007 Scil Technology GmbH obtained Competent Authority Approval for Phase II Periodontitis Study
23 May 2007 Phase 1b insulin clinical trial commenced
23 May 2007 Voraxaze (TM) Update
22 May 2007 Roche receives approvable letter for Mircera in the United States
22 May 2007 Intarcia Therapeutics Announces Presentation of Final Results from a Phase 2 Combination Study for the Treatment of Hepatitis C at the Digestive Disease Week Conference
19 May 2007 Curis Provides Update on BMP-7 Program
16 May 2007 Phylogica Generates Multiple Drug Candidates For Treatment Of Rheumatoid Arthritis
16 May 2007 OMRIX Biopharmaceuticals Receives Food and Drug Administration (FDA) Approval for Liquid Fibrin Sealant, Evicel(TM), For Use in Vascular Surgery
15 May 2007 Dyax Corp. Treats First Patient in Phase 2 Trial for On-Pump Cardiothoracic Surgery
15 May 2007 Actilyse(R) (alteplase) recommended by National Institute for Health and Clinical Excellence for treatment of acute ischaemic stroke
15 May 2007 Acceleron Pharma's ACE-031 Increases Muscle Mass and Strength in Preclinical Studies
15 May 2007 Nautilus Biotech receives FDA approval for Phase 1 clinical trial in the USA for oral Belerofon(R), its long-lasting, Interferon-alpha drug
11 May 2007 Viropro Inc. and Intas Biopharmaceuticals Announce the Signature of a Binding MOU for the Development and Production of a Therapeutic Protein
10 May 2007 FDA Advisory Committee Reviews Data on IDM Pharma's Junovan(TM) (mifamurtide) for Treatment of Osteosarcoma
10 May 2007 Altus Pharmaceuticals Initiates Phase III Clinical Trials of ALTU-135 for Cystic Fibrosis Patients with Pancreatic Insufficiency
09 May 2007 Oramed Pharmaceuticals Begins Phase 1 Human Clinical Trials
09 May 2007 AEterna Zentaris Regains Exclusive Worldwide (ex-Japan) Rights from Solvay for Cetrorelix in Endometriosis Indication
09 May 2007 Multiferon(R) Shows Potent Activity in Preventing the Progression of Malignant Melanoma; Study to be Published
08 May 2007 Pacgen Announces Positive Results from Phase I/II Trial of Novel Anti-Fungal Drug

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up